Melanoma Clinical Trials in Dallas

Showing 241-260 of 268 trials

Vaccine Therapy in Treating Patients With Metastatic Melanoma

NCT00003792

RATIONALE: Vaccines made from a person's white blood cells and melanoma cells may make the body build an immune response and kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have metastatic melanoma.

Melanoma (Skin)

Baylor Health Care SystemStarted Apr 1999

Dallas, Texas, United States

COMPLETEDPhase 2< 1 mile

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

NCT00104988

RATIONALE: Thalidomide may stop the growth of melanoma by blocking blood flow to the tumor. It may also stimulate the immune system in different ways and stop tumor cells from growing. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving thalidomide together with temozolomide may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving thalidomide together with temozolomide works in treating patients with stage IV melanoma that cannot be removed by surgery.

Melanoma (Skin)

SWOG Cancer Research Network64 participantsStarted Jun 2005

Anchorage, Alaska, United States • Little Rock, Arkansas, United States • Castro Valley, California, United States +129 more locations

Vaccine Therapy in Treating Patients With Metastatic Melanoma

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Melanoma Trials in Other Cities

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

A Study of Volociximab in Metastatic Melanoma

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Study of XL281 in Adults With Solid Tumors

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

CP-675,206 In Patients With Advanced Melanoma

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Study of CP-675,206 in Refractory Melanoma

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System

Other Conditions in Dallas